Log in


  • Home
  • Genome-scale signatures of gene interaction from compound screens predict clinical efficacy of targeted cancer therapies.

Donation goal

0%
Goal:
$500.00
Collected:
$0.00

Genome-scale signatures of gene interaction from compound screens predict clinical efficacy of targeted cancer therapies.

  • Fri, March 30, 2018
  • https://www.eventbrite.com/e/genome-scale-signatures-of-gene-interaction-from-compound-screens-predict-clinical-efficacy-of-tickets-42839542224

Genome-scale signatures of gene interaction from compound screens predict clinical efficacy of targeted cancer therapies.
Date: March 30th, 2018
Speaker: Dr. Peng Jiang, Shirley Liu Lab at Dana Farber Cancer Institute and Harvard School of Public Health.
Video: https://youtu.be/9I8l5fP_dtw
Presentation: Download

文本转语音功能仅限200个字符
选项 : 历史 : 反馈 : Donate 关闭



@Dahshu 2020

文本转语音功能仅限200个字符
选项 : 历史 : 反馈 : Donate 关闭
G
M
T
Y
文本转语音功能仅限200个字符
Powered by Wild Apricot Membership Software